What he says is true. The risk with R&D spend though is not all of it is productive - and that risk is not fully in the price. For example, CSL’s reporter “cholostrol killer” could fall flat.
Not selling CSL if you have been holding is different to buying more at today’s prices.
CSL Chart, page-370
-
- There are more pages in this discussion • 740 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$300.36 |
Change
-1.150(0.38%) |
Mkt cap ! $145.5B | |||
| Open | High | Low | Value | Volume |
| $303.22 | $303.24 | $298.45 | $51.30M | 170.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 40 | $300.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $300.37 | 30 | 2 |
View Market Depth
| Last trade - 13.50pm 11/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |